Back to Journals » Vascular Health and Risk Management » Volume 8

New oral antithrombotics: focus on dabigatran, an oral, reversible direct thrombin inhibitor for the prevention and treatment of venous and arterial thromboembolic disorders

Total article views   HTML views PDF downloads Totals
15,946 Dovepress* 11,363+ 3,158 14,521
PubMed Central* 4,583 2,451 7,034
Totals 15,946 5,609 21,555
*Since 25 January 2012
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 1 1

View citations on PubMed Central and Google Scholar